Distinct rat aortic smooth muscle cells differ in versican/PG-M expression

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 6, 1996, Pages 821-829

  Lemire, Joan M ^a   Potter Perigo, Susan ^b   Hall, Keith L ^a   Wight, Thomas N ^b   Schwartz, Stephen M ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

artery; differentiation; PG M; proteoglycans; versican

Indexed keywords

ANTIBODY; BIGLYCAN; CHONDROITIN ABC LYASE; DECORIN; GLYCOSAMINOGLYCAN; PERLECAN; PROTEOGLYCAN; RNA; SULFATE; VERSICAN;

AORTA MEDIA; ARTICLE; GENE EXPRESSION; IMMUNOBLOTTING; ION EXCHANGE CHROMATOGRAPHY; NONHUMAN; NORTHERN BLOTTING; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER;

EID: 0029952190     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.6.821     Document Type: Article

References (71)

1. Majesky MW, Schwartz SM. Smooth muscle diversity in arterial wound repair. Toxicol Pathol. 1990;18:554-559.
2. Majesky MW, Giachelli CM, Reidy MA, Schwartz SM. Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated mRNA phenotype during repair of arterial injury. Circ Res. 1992;71:759-768.
3. Giachelli C, Bae N, Lombardi D, Majesky M, Schwartz S. Molecular cloning and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I, 2aR). Biochem Biophys Res Commun. 1991;177:867-873.
4. Lemire JM, Covin CW, White S, Giachelli CM, Schwartz SM. Characterization of cloned aortic smooth muscle cells from young rats. Am J Pathol. 1994;144:1068-1081.
5. Majesky MW, Benditt EP, Schwartz SM. Expression and developmental control of platelet-derived growth factor A-chain and B-chain/Sis genes in rat aortic smooth muscle cells. Proc Natl Acad Sci U S A. 1988;85:1524-1528.
6. Walker LN, Bowen Pope DF, Ross R, Reidy MA. Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc Natl Acad Sci USA. 1986;83:7311-7315.
7. Giachelli CM, Majesky MW, Schwartz SM. Developmentally regulated cytochrome P-450IA1 expression in cultured rat vascular smooth muscle cells. J Biol Chem. 1991;266:3981-3986.
8. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest. 1993;92:1686-1696.
9. Orlandi A, Ehrlich HP, Ropraz P, Spagnoli LG, Gabbiani G. Rat aortic smooth muscle cells isolated from different layers and at different times after endothelial denudation show distinct biological features in vitro. Arterioscler Thromb. 1994;14:982-989.
10. Blaes N, Bourdillon M-C, Daniel-Lamaziere J-M, Michaille J-J, Andujar M, Covacho C. Isolation of two morphologically distinct cell lines from arterial smooth muscle cells expressing high tumorigenic potentials. In Vitro Cell Dev Biol. 1991;27A:725-734.
11. Dreher KL, Cowan K. Expression of antisense transcripts encoding an extracellular matrix protein by stably transfected vascular smooth muscle cells. Eur J Cell Biol. 1991;54:1-9.
12. Fugita H, Shimokada K, Yutani C, Takaichi S, Masuda J, Ogata J. Human neonatal and adult vascular smooth muscle cells in culture. Exp Mol Pathol. 1993;58:25-39.
13. Campbell GR, Campbell JH. Smooth muscle phenotypic changes in arterial wall homeostasis: implications for the pathogenesis of atherosclerosis. Exp Mol Pathol. 1985;42:139-162.
14. Gordon D, Mohai LG, Schwartz SM. Induction of polyploidy in cultures of neonatal rat aortic smooth muscle cells. Circ Res. 1986; 59:633-644.
15. Hamati HF, Britton EL, Carey DJ. Inhibition of proteoglycan synthesis alters extracellular matrix deposition, proliferation, and cytoskeletal organization of rat aortic smooth muscle cells in culture. J Cell Biol. 1989;108:2495-2505.
16. Wight TN. Cell biology of arterial proteoglycans. Arteriosclerosis. 1989;9:1-20.
17. Yao LY, Moody C, Schonherr E, Wight TN, Sandell LJ. Identification of the proteoglycan versican in aorta and smooth muscle cells by DNA sequence analysis, in situ hybridization and immuno-histochemistry. Matrix Biol. 1994;14:213-225.
18. Schonherr E, Jarvelainen HT, Sandell LJ, Wight TN. Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J Biol Chem. 1991;266: 17640-17647.
19. Schonherr E, Jarvelainen HT, Kinsella MG, Sandell LJ, Wight TN. Platelet-derived growth factor and transforming growth factor-β1 differentially affect the synthesis of biglycan and decorin by monkey arterial smooth muscle cells. Arterioscler Thromb. 1993;13: 1026-1036.
20. Zimmermann DR, Ruosiahti E. Multiple domains of the large fibroblast proteoglycan, versican. EMBO J. 1989;8:2975-2981.
21. Shinomura T, Nishida Y, Ito K, Kimata K. CDNA cloning of PG-M, a large chondroitin sulfate proteoglycan expressed during chondrogenesis in chick limb buds: alternative spliced multiforms of PG-M and their relationships to versican. J Biol Chem. 1993;268: 14461-14469.
22. Yamagata M, Suzuki S, Akiyama SK, Yamada KM, Kimata K. Regulation of cell substrate adhesion by proteoglycans immobilized on extracellular substrates. J Biol Chem. 1989;264:8012-8018.
23. Yamagata M, Saga S, Kato M, Bernfield M, Kimata K. Selective distributions of proteoglyeans and their ligands in pericellular matrix of cultured fibroblasts: implications for their roles in cell-substratum adhesion. J Cell Sci. 1993;106:55-65.
24. Wolf YG, Rasmussen LM, Ruosiahti E. Antibodies against transforming growth factor-beta 1 suppress intimai hyperplasia in a rat model. J Clin Invent. 1994;93:1172-1178.
25. Wight TN. The vascular extracellular matrix. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. New York, NY: Raven Press; 1996:421-440.
26. Lark MW, Yeo TK, Mar H, Lara S, Hellstrom I, Hellstrom KE, Wight TN. Arterial chondroitin sulfate proteoglycan: localization with a monoclonal antibody. J Histochem Cytochem. 1988;36: 1211-1221.
27. Camejo G, Hurt Camejo E, Olsson U, Bondjers G. Proteoglycans and lipoproteins in atherosclerosis. Curr Opin Lipidol 1993;4: 385-391.
28. Jackson RL, Busch SJ, Cardin AD. Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol Rev. 1991;71:481-539.
29. Hall KL, Harding JW, Hosick HL. Isolation and characterization of clonal vascular smooth muscle cell lines from spontaneously hypertensive and normotensive rat aortas. In Vitro Cell Dev Biol. 1991; 27A:791-798.
30. Wasteson A, Uthne K, Westermark B. A novel assay for the biosynthesis of sulphated polysaccharide and its application to studies on the effects of somatomedin on cultured cells. Biochem J. 1973; 136:1069-1074.
31. Hascall VC, Kimura JH. Proteoglycans: isolation and characterization. Methods Enzymol. 1982;82:769-800.
32. Saitoh H, Yamagata T, Suzuki S. Enzymatic methods for the determination of small quantities of isomeric chondroitin sulfates. J Biol Chem. 1968;243:1536-1542.
33. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
34. Madri JA, Roll FJ, Furthmayr H, Foidart J-M. Ultrastructural localization of fibronectin and laminin in the basement membrane of the murine kidney. J Cell Biol. 1980;86:682-697.
35. LeBaron RG, Zimmermann DR, Ruosiahti E. Hyaluronate binding properties of versican. J Biol Chem. 1992;267:10003-10010.
36. Apotolski S, Sadiq SA, Hays A, Corbo M, Suturkova-Milosevic L, Chaliff P, Stefansson K, LeBaron RG, Hays AP, Latov N. Identification of Gal(β1-3)GalNAc bearing glycoproteins at the nodes of Ranvier in peripheral nerve. J Neurosci Res. 1994;38:134-141.
37. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, eds. Current Protocols in Molecular Biology, 1. New York, NY: Wiley Press; 1987.
38. Dodge GR, Kovalszky I, Chu ML, Hassell JR, McBride OW, Yi HF, Iozzo RV. Heparan sulfate proteoglycan of human colon: partial molecular cloning, cellular expression, and mapping of the gene (HSPG2) to the short arm of human chromosome 1. Genomics. 1991; 10:673-680.
39. Day AA, McQuilian CI, Termine JD, Young MR. Molecular cloning and sequence analysis of the cDNA for small proteoglycan II of bovine bone. Biochem J. 1987;248:801-805.
40. Fisher LW, Termine JD, Young MF. Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J Biol Chem. 1989;264:4571-4576.
41. Tso JY, Sun X-H, Kao T-H, Reece KS, Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 1985;13:2485-2502.
42. Ito K, Shinomura T, Zako M, Ujita M, Kimata K. Multiple forms of mouse PG-M, a large chondroitin sulfate proteoglycan generated by alternative splicing. J Biol Chem. 1995;270:958-965.
43. Chang Y, Yanagishita M, Hascall VC, Wight TN. Proteoglycans synthesized by smooth muscle cells derived from monkey (Macaca nemestrina) aorta. J Biol Chem. 1983;258:5679-5688.
44. Yeo TK, Macfarlane S, Wight TN. Characterization of a chondroitin sulfate proteoglycan synthesized by monkey arterial smooth muscle cells in vitro. Connect Tissue Res. 1992;27:265-277.
45. Seifert RA, Schwartz SM, Bowen-Pope DF. Developmentally regulated production of platelet-derived growth factor-like molecules. Nature. 1984;311:669-671.
46. Dours-Zimmermann MT, Zimmermann DR. A novel glycosaminoglycan attachment domain identified in two alternative splice variants of human versican. J Biol Chem. 1994;269:32992-32998.
47. Zako M, Shinomura T, Ujita M, Ito K, Kimata K. Expression of PG-M (V3), an alternatively spliced form of PG-M without a chondroitin sulfate attachment region in mouse and human tissues. J Biol Chem. 1995;270:3914-3918.
48. Potter-Perigo S, Braun KR, Schonherr E, Wight TN. Altered proteoglycan synthesis via the false acceptor pathway can be dissociated from beta-D-xyloside inhibition of proliferation. Arch Biochem Biophys. 1992;297:101-109.
49. Pauly RR, Passaniti A, Crow M, Kinsella JL, Papadopoulos N, Monticone R, Lakatta EG, Martin GR. Experimental models that mimic the differentiation and dedifferentiation of vascular cells. Circulation. 1992;86(suppl III):III-68-III-73.
50. Hedin U, Sjolund M, Hultgardh-Nilsson A, Thyberg J. Changes in expression and organization of smooth-muscle-specific α-actin during fibronectin-mcdiated modulation of arterial smooth muscle cell phenotype. Differentiation. 1990;44:222-231.
51. Thyberg J, Hedin U, Sjolund M, Palmberg L, Boftger BA. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis. 1990;10:966-990.
52. Thyberg J, Hultgardh-Nilsson A. Fibronectin and the basement membrane components laminin and collagen type IV influence the phenotypic properties of subcultured rat aortic smooth muscle cells differently. Cell Tissue Res. 1994;276:263-271.
53. Elenius K, Jalkanen M. Function of the syndecans: a family of cell surface protcoglycans. J Cell Sci. 1994;107:2975-2982.
54. Kato M, Saunders S, Nguyen H, Bernfield M. Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells. Mol Biol Cell. 1995;6:559-576.
55. Leppa S, Mali M, Miettinen HN, Jalkanen M. Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells. Proc Natl Acad Sci USA. 1992;89:932-936.
56. Cizmeci-Smith G, Stahl R, Showalter L, Carey D. Differential expression of transmembrane proteoglycans in vascular smooth muscle. J Biol Chem. 1993;268:18740-18747.
57. Nikkari ST, Jarvelainen HT, Wight TN, Ferguson TN, Clowes AW. Smooth muscle cell expression of extracellular matrix genes after arterial injury. Am J Pathol. 1994;144:1348-1356.
58. Cizmeci-Smith G, Asundi V, Stahl RC, Teichman LJ, Chernousov M, Cowan K, Carey DJ. Regulated expression of syndecan in vascular smooth muscle cells and cloning of rat syndecan core protein cDNA. J Biol Chem. 1992;267:15729-15736.
59. Yeo TK, Yeo KT, Wight TN. Differential transport kinetics of chondroitin sulfate and dermatan sulfate proteoglycan by monkey aorta smooth muscle cells. Arch Biochem Biophys. 1992;294:9-16.
60. Krusius T, Gehlsen KR, Ruoslahti E. A fibroblast chondroitin sulfate proteoglycan core protein contains lectin-like and growth factor-like sequences. J Biol Chem. 1987;262:13120-13125.
61. Aspberg A, Binkert C, Ruoslahti E. The versican C-type lectin domain recognizes the adhesion protein tenascin-R (J1-160/180, Januscin). Proc Natl Acad Sci USA. 1995;92:10590-10594.
62. Ujita M, Shinomura T, Ito K, Kitagawa Y, Kimata K. Expression and binding activity of the carboxy-terminal portion of the core protein of PG-M, a large chondroitin sulfate proteoglycan. J Biol Chem. 1994;269:27603-27609.
63. Yamagata M, Kimata K. Repression of a malignant cell-substratum adhesion phenotype by inhibiting the production of the antiadhesive proteoglycan, PGM/versican. J Cell Sci. 1994;107: 2581-2590.
64. Kirjavainen J, Leppa S, Hynes N, Jalkanen M. Translational suppression of syndecan-1 expression in Ha-ras transformed mouse mammary epithelial cells. Mol Biol Cell. 1993;4:849-858.
65. Morris J. Proteoglycans and the modulation of cell adhesion by steric exclusion. Dev Dyn. 1993;196:246-251.
66. Schwartz SM, Reidy MR, Clowes A. Kinetics of atherosclerosis: a stem cell model. Ann NY Acad Sci. 1985;454:292-304.
67. Lindner V, Giachelli CM, Schwartz SM, Reidy MA. A subpopulation of smooth muscle cells in injured rat arteries expresses PDGF-B chain mRNA. Circ Res. 1995;76:951-957.
68. Majesky MW, Reidy MA, Bowen Pope DF, Hart CE, Wilcox JN, Schwartz SM. PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol. 1990;111:2149-2158.
69. Qwarnstrom EE, Jarvelainen HT, Kinsella MG, Ostberg CO, Sandell LJ, Page RC, Wight TN. Interleukin-1 beta regulation of fibroblast proteoglycan synthesis involves a decrease in versican steady-state mRNA levels. Biochem J. 1993;294:613-620.
70. Ikeda T. Shirasawa T, Esaki Y, Yoshiki S, Hirokawa K. Osteopontin mRNA is expressed by smooth muscle cells in human atherosclerotic lesions of the aorta. J Clin Invest. 1993;92:2814-2820.
71. Hirota S, Imakita M, Kohri K, Ito A, Morii E, Adachi S, Kim HM, Kitamura Y, Yutani C, Nomura S. Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques: a possible association with calcification. Am J Pathol. 1993;143:1003-1008.